Oct 24,2018

Promising study results for digital behavioral therapies

Data from two clinical trials presented at the annual conference of the American College of Lifestyle Medicine give credence to digitally-delivered behavioral interventions developed by Better Therapeutics. The first observed an average A1c reduction of .8 percent among Type 2 diabetes patients receiving 12 weeks of the digital treatment. The other, conducted among hypertension patients, saw an average systolic blood pressure drop of 11.4 mmHg.

PRODUCT

#cbt

#pdt

View Analyst & Ambassador Comments
Go to original news
Jun 20,2018

Omada Health Adds New Programs for Type 2 Diabetes and Hypertension Self-Management

Omada Health today announced the availability of new programs that will help individuals control type 2 diabetes and hypertension. Adding to Omada’s industry-leading diabetes prevention program, the company will now offer integrated condition management programs for enterprise and health plan customers, significantly expanding the populations Omada serves. Leveraging seven years of data-driven insights; integration experience with hundreds of health plan and employer customers; and a proven approach to sustainable lifestyle change, Omada will now provide personalized interventions for those at-risk for, or with, certain obesity-related chronic conditions.

PRODUCT

#coaching

#rpm

View Analyst & Ambassador Comments
Go to original news
Apr 08,2016

California hospital becomes first in US to prescribe ingestible sensors from Proteus

Redwood City, California-based Proteus Digital Health announced its first US healthcare provider customer, Barton Health, which will prescribe the company's Proteus Discover to patients. The company says this is the first time its technology has been implemented outside of a clinical trial setting in the US. Barton Health, a health system in Lake Tahoe, California, will use the medication adherence platform, which includes Proteus’s FDA-cleared ingestible sensor, in populations with uncontrolled and co-morbid hypertension. Implementation for other chronic conditions will follow if the first use case goes well.

COLLABORATION PARTNERSHIP

#institution

#connected device

#pdt

View Analyst & Ambassador Comments
Go to original news
Dec 08,2022

Omada Health is the First Virtual Care Company to Join the Institute for Healthcare Improvement Leadership Alliance

Omada Health, a virtual, integrated chronic care provider, joined the Institute for Healthcare Improvement (IHI) Leadership Alliance as its first virtual health member. The Leadership Alliance is a dynamic collaboration of health care providers united by a common mission — to work with one another and in partnership with patients, workforces, and communities to deliver the full promise of the IHI Triple Aim: improve the health of populations, enhance the experience of patients, and reduce the per capita cost of care.

#virtual care

View Analyst & Ambassador Comments
Go to original news
Nov 17,2022

K Health Platform Now Addressing Weight Loss to Help Prevent and Manage Multiple Chronic Conditions

Clinical healthcare company K Health announced today that the remote Primary Care program available on its platform now includes online medical weight management to treat obesity and help prevent related chronic conditions like hypertension and type 2 diabetes. K Health has partnered with leaders in the healthcare space to tackle chronic disease, most recently through its collaboration with Mayo Clinic Platform on the development of an artificial intelligence (AI) predictive model that uses Mayo Clinic data to help doctors optimize hypertension treatment.

PRODUCT

#virtual care

View Analyst & Ambassador Comments
Go to original news
Jan 05,2022

Welldoc Granted 25th US Patent, Expanding Company’s Platform Solution Capabilities

Welldoc®, a digital health leader revolutionizing chronic care, today announced that the company’s 25th patent was approved by the U.S. Patent and Trademark Office on December 8, 2021.

PRODUCT

#mobile app

View Analyst & Ambassador Comments
Go to original news
Feb 09,2022

One Drop’s Multi-Condition Program Achieves Third-Party Validation for Simultaneous Improvement of Blood Glucose and Blood Pressure Outcomes

One Drop, a leader in precision health solutions for people living with chronic conditions worldwide, today announced its multi-condition program has received validation for clinical outcomes from Validation Institute, an objective, independent organization that evaluates data claims made by healthcare solutions providers. Validation Institute financially guarantees that One Drop's multi-condition support program can drive statistically significant blood glucose and blood pressure reductions for members with prediabetes, diabetes, and/or hypertension who had one or more lessons completed or interactions with a health coach over 30 to 180 days.

PRODUCT

#mobile app

View Analyst & Ambassador Comments
Go to original news
Feb 11,2022

Biofourmis Expands Into Virtual Specialty Care With The Launch Of Biofourmis Care

Biofourmis, a Boston-based global leader in virtual care and digital therapeutics, announced the launch of Biofourmis Care, a first of its kind, technology-enabled care management service that delivers high-quality remote care for patients with chronic conditions. The service includes automated medication management to augment and assist care teams in remotely adjusting medications for optimal personalized therapy. Biofourmis Care currently includes five virtual care programs: heart failure, hypertension, diabetes, lipid management and atrial fibrillation.

PRODUCT

#rpm

#virtual care

View Analyst & Ambassador Comments
Go to original news
Mar 09,2022

DarioHealth Announces Two New Contracts within the Employer and Provider Market

DarioHealth Corp. (Nasdaq: DRIO), a leader in the global digital therapeutics (DTx) market, announced today new agreements with a regional employer and a regional provider. The contracts are expected to launch in the second quarter of 2022. The new employer client will deploy Dario's digital behavioral solution to improve access to outcomes-based care, and the new provider contract will deliver both diabetes and hypertension solutions to patients.

PRODUCT

#coaching

#mobile app

View Analyst & Ambassador Comments
Go to original news
Mar 09,2022

Omada Health Announces Integrated Behavioral Health Support Across Chronic Care Programs

In the heels of Omada Health’s $192 million Series E, the digital health company announced at Mindset 2022 today that it’s investing more deeply in its collaborative care model by embedding its behavioral health support into all existing programs (Diabetes Prevention, Diabetes Management, Hypertension and Musculoskeletal). As a virtual-first care leader, Omada is continually evolving its programs with a goal of providing better, more integrated care to those living with chronic conditions. This latest integration offers members care that approaches both mental and physical health equally to help remove barriers and lead to better outcomes.

PRODUCT

#virtual care

View Analyst & Ambassador Comments
Go to original news
Subscribe to HYPERTENSION